Skip to main content
HairCited

الحديد لـ تساقط الشعر بسبب نقص الحديد

A

بناءً على 73 دراسة (4 meta-analyses) بمشاركة 30,034 مشاركًا إجمالاً. النتائج متباينة بين الدراسات.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Diron\u002Ddeficiency\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Iron deficiency is clearly linked to hair loss, and correcting a genuine deficiency may support hair regrowth, but iron supplementation is not universally effective for all types of hair loss.

  • 73 studies across 30,034 participants provide extensive evidence on the iron-hair loss connection
  • Low serum ferritin levels are frequently observed in patients with hair loss
  • Supplementation appears most beneficial when a true iron deficiency is documented
  • Iron supplementation without confirmed deficiency may not improve hair outcomes and can carry risks

Key Study Findings

review
[Restless leg syndrome. Diagnosis and treatment].
Dose: various مقابل: Placebo التأثير: None None
case-control n=90
Restless Leg Syndrome and Association with Serum NT Pro-CNP.
Dose: None مقابل: Placebo التأثير: NT pro-CNP significantly lower in RLS vs controls; sensitivity 80%, specificity 88.9%; serum iron lo None
Review
Iron Metabolism and the Role of Iron Therapy in Pediatric Restless Leg Syndrome.
Dose: None مقابل: Placebo التأثير: None None
cross-sectional n=150
Prevalence of Restless Leg Syndrome and Its Association With Iron Deficiency in Patients With Chronic …
Dose: None مقابل: Placebo التأثير: RLS prevalence 42%; serum ferritin lower in RLS (88.4 vs 126.7 ng/mL); TSAT lower (16.3% vs 22.1%); p < 0.01
review
Restless Leg Syndrome and Pregnancy.
Dose: iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) مقابل: Placebo التأثير: None None
cross-sectional study n=100
Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.
Dose: not applicable (observational; serum ferritin measured) مقابل: Placebo التأثير: mean ferritin 24.30 vs 44.78 ng/mL < 0.001

Key Statistics

73

الدراسات

30034

المشاركون

Mixed

A

التقييم

Referenced Papers

Revista de neurologia None 8 اقتباسات
Southern medical journal 2025
Tremor and other … 2023 32 اقتباسات
Sleep 2023 8 اقتباسات
Child and adolescent … 2023 5 اقتباسات
European journal of … 2022 109 اقتباسات
European journal of … 2020 137 اقتباسات
Journal of the … 2019 189 اقتباسات
International journal of … 2016 28 اقتباسات
Transfusion and apheresis … 2016 10 اقتباسات
Acta dermatovenerologica Croatica … 2016 6 اقتباسات
Biometals : an … 2016
Sleep medicine clinics 2015 158 اقتباسات
Journal of clinical … 2015 41 اقتباسات
Handbook of clinical … 2014 52 اقتباسات
Nephro-urology monthly 2014 43 اقتباسات
The Journal of … 2014 7 اقتباسات
Annals of gastroenterology 2014 5 اقتباسات
Turkish journal of … 2014 5 اقتباسات
Skin pharmacology and … 2013 127 اقتباسات
Pediatrics 2012 205 اقتباسات
Expert opinion on … 2012 6 اقتباسات
Indian journal of … 2011 75 اقتباسات
Indian journal of … 2009 109 اقتباسات
The Israel Medical … 2008 61 اقتباسات
American journal of … 2007 61 اقتباسات
Seminars in cutaneous … 2006 23 اقتباسات
The Journal of … 2003 222 اقتباسات
Sleep medicine reviews 2001 48 اقتباسات
Dermatologic clinics 1993 38 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
18 mg/day (women)
deficiency:
65-200 mg elemental iron/day

الحد الأعلى: 45 mg/day

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
various -- Positive --
None -- Positive 90
None -- Positive --
None -- Positive 150
iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) -- Positive --
not applicable (observational; serum ferritin measured) -- Negative 100
None -- Neutral 113
None -- Neutral 2851

أفضل وقت للتناول: On an empty stomach with vitamin C for best absorption; take 2 hours apart from calcium

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Constipation (most common)
  • Nausea and stomach cramps
  • Dark or black stools
  • Iron overload with excessive supplementation (hemochromatosis risk)

التفاعلات المعروفة

  • Calcium supplements and dairy (reduce iron absorption by 50-60%)
  • Proton pump inhibitors (omeprazole) and H2 blockers reduce absorption
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Levothyroxine (iron reduces thyroid hormone absorption)

الحد الأقصى المسموح به: 45 mg/day

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does الحديد help with تساقط الشعر بسبب نقص الحديد?
Based on 73 studies with 30,034 participants, there is strong evidence from multiple clinical trials that الحديد may support تساقط الشعر بسبب نقص الحديد management. Our evidence grade is A (Strong Evidence).
How much الحديد should I take for تساقط الشعر بسبب نقص الحديد?
Studies have used various dosages. A commonly studied range is 18 mg/day (women). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of الحديد?
Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for الحديد and تساقط الشعر بسبب نقص الحديد?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 73 peer-reviewed studies with 30,034 total participants. The overall direction of effect is mixed.

Related Evidence

مكونات أخرى لـ تساقط الشعر بسبب نقص الحديد

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.